PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) Stock Price, Quote, News & History

Key Statistics

Open

$0.04

Volume / Avg.

17.27K / 136.54K

Day Range

$0.04 - $0.04

52 Wk Range

0.03 - 0.33

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Pharmather Holdings Ltd News

Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years, NY Consulting Firm Predicts

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.

Lara Goldstein

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More

Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification

Lara Goldstein

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More

Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal prosecution for possession, use, purchase, cultivation and engaging in practices with “entheogenic plants or plant compounds."

Lara Goldstein

PharmaTher's DMT Patch Shows Positive Outcomes, Investment Toward The Clinical Stage

PharmaTher Holdings (OTCQB: PHRRF) and the Terasaki Institute for Biomedical Innovation evaluated the former’s novel microneedle patch for the delivery of DMT, and research yielded positive outcomes.

Lara Goldstein

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

World's Largest Psychedelics Conference Boasts 12K Attendees

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-680.44K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

250.00K

Free Cash Flow (TTM)

-680.44K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-430.44K

Valuation Metrics

Enterprise Value

$3.34M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

10.08

Earnings Yield % (TTM)

-33.86%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$794.80K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.04

Volume / Avg.

17.27K / 136.54K

Day Range

$0.04 - $0.04

52 Wk Range

0.03 - 0.33

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KET...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

PHRRF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

PHRRF

FAQ

How do I buy PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) stock?

You can purchase shares of PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (OTCQB:PHRRF) through any online brokerage.

View our list of the best stock brokerages

Who are PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) competitors?

There are no as such competitors for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd..

What is the forecast, or price target, for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) stock?

There is no analysis for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. to provide a consensus price target.

What is the current price for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF)?

The stock price for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (OTCQB: PHRRF) is $0.044 last updated August 21, 2026 at 2:59 PM EDT.

Does PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) pay a dividend?

There are no upcoming dividends for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd..

When is PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (OTCQB:PHRRF) reporting earnings?

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. does not have any upcoming earnings scheduled.

Is PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) going to split?

There is no upcoming split for PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd..

What sector and industry does PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. (PHRRF) operate in?

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.